Uroplasty (UPI) Reports a Q4 Loss; CEO Comments on Fiscal 2011 Outlook
Tweet Send to a Friend
Uroplasty, Inc. (NYSE Amex: UPI) reports a Q4 loss of $0.04 compared to an $0.11 loss for the same period ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


